Your browser doesn't support javascript.
loading
Primary Cutaneous Anaplastic Large Cell Lymphoma of the Oral Cavity Successfully Treated with Brentuximab Vedotin.
Meconi, Federico; Secchi, Roberto; Palmieri, Raffaele; Vaccarini, Sara; Rapisarda, Vito Mario; Giannì, Laura; Esposito, Fabiana; Provenzano, Ida; Nasso, Daniela; Pupo, Livio; Cantonetti, Maria.
Afiliação
  • Meconi F; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Secchi R; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Palmieri R; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Vaccarini S; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Rapisarda VM; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Giannì L; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Esposito F; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Provenzano I; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Nasso D; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Pupo L; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
  • Cantonetti M; Department of Biomedicine and Prevention, Haematology Division, University of Tor Vergata, Viale Oxford 81, Rome, Italy.
Case Rep Hematol ; 2019: 9651207, 2019.
Article em En | MEDLINE | ID: mdl-31637066
ABSTRACT
Primary cutaneous anaplastic large cell lymphoma is a CD-30 positive lymphoproliferative disorder with good prognosis, usually treated with radiation therapy and surgery. Head, neck, and extremities are the most frequently involved sites. In this paper, we describe an unusual case of oral localization, recurring after skin-involving radiotherapy, successfully treated with sixteen cycles of brentuximab vedotin. This could be a more effective approach with a less detrimental toll for treating these rare disorders.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália